The Mark Cuban Cost Plus Drug Company is jumping into the online pharmacy sector, launching a new digital marketplace. The company pitches the digital pharmacy as a way to help consumers find medications for less money.
In November, the company unveiled its pharmacy benefit manager (PBM) operation, which the company says lets them cut out the "middlemen" and price markups in their online...
Alphabet's life-science subsidiary Verily is teaming up with cosmetics giant L'Oréal in an effort to better understand skin care and develop new digital tools in the dermatology space. The partners plan to study dermatological health over time to better understand the environment and aging's impact on skin and the "deep biology of the skin."
Verily's R&D team and L'Oréal's Active Cosmetic...
Qure.ai scored FDA 510(k) clearance for its artificial intelligence algorithm that assists providers in placing breathing tubes.
The clearance, which officially came down in late December, is the company's third 510(k). The two previous FDA green lights were regarding its brain CT scan product.
Using chest x-rays, the qXR-BT algorithm can analyze the position of the breathing tube. It automates...
Biopharma giant Sanofi is setting its sights on AI for drug discovery, inking a deal worth more than $100 million with tech company Exscientia.
As part of the deal, Exscientia is eligible for as much as $5.2 billion in payments for clinical development, regulatory and commercial milestones.
The deal will revolve around the development of up to 15 novel small molecule candidates in oncology and...
Diagnostic company Cue Health announced on Thursday that it will create an Omicron-genotyping COVID-19 test.
The test will be used in professional care settings to specifically detect the Omicron variant in nasal samples. The work is part of a partnership with HHS’ Biomedical Advanced Research and Development Authority (BARDA).
"An Omicron-specific test will assist clinicians in providing...
Seattle-based startup Curi Bio landed $10 million in Series A funding for its stem cell-focused drug-exploration platforms.
This investment comes months after the company announced a $6 million funding round led by Dynamk Capital.
WHAT IT DOES
Curi Bio developed a platform called Mantrarry, which is able to help scientists “generate and analyze 3D engineered human muscle tissues.” The company's...
Over the last decade, the life sciences industry has increasingly adopted more digital tools to assist in research, treatment and data collection. This trend was accelerated during the COVID-19 pandemic. In fact, in 2021 we’ve seen more digital therapeutics emerge onto the market, while pharma companies and startups work together on collecting real-world data, and investments continue in...
Canadian digital pharmacy Mednow has entered into agreements to purchase Liver Care Canada and London Pharmacare. The news comes about a week after it completed its acquisition of Infusicare Canada, another specialty pharmacy.
Under the terms of the non-arm’s length party transactions, Mednow will acquire Liver Care Canada for initial cash payment of C$65,000 and two subsequent earn-out payments...
PharmStars, a digital health accelerator focused on forging relationships between digital health companies and the life science world, has announced the culmination of its first 10-week program focused on clinical trial innovation.
Founded by digital health vet Naomi Fried and pharmaceutical exec Laura Gunn in 2021, the program is focused on educating health tech companies and pharma on working...
_5f57e.jpg)
_47bb4.jpg)
_3c30e.jpg)
_27cb5.jpg)
